医麦客新闻 eMedClub News
近日,Altamira Therapeutics宣布与Univercells Group达成合作协议,以评估该公司专有的、基于肽的SemaPhore平台在mRNA疫苗递送方面的应用,SemaPhore平台有望代替LNP递送系统,在mRNA领域中有广泛地应用潜力。如果实验成功,Univercells和Altam...查看全文
医麦客03-28 10:35
2024年3月28日
医麦客新闻 eMedClub News
近日,Altamira Therapeutics宣布与Univercells Group达成合作协议,以评估该公司专有的、基于肽的SemaPhore平台在mRNA疫苗递送方面的应用,SemaPhore平台有望代替LNP递送系统,在mRNA领域中有广泛地应用潜力。如果实验成功,Univercells和Altam...查看全文
F1watch2023-07-05 18:20
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-07-05 AccNo: 0001213900-23-054243 Size: 1 MB 网页链接查看全文
F1watch2023-06-17 05:20
F-1 - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-06-16 AccNo: 0001213900-23-049716 Size: 500 KB 网页链接查看全文
稳妥的回报将军2023-06-16 09:18
上周多伦多证券交易所创业板(TSXV)涨幅最大的资源股是Solis Minerals、MacArthur Minerals、Altamira Gol、VR Resources和Tier One Silver。虽然大盘The S&P/TSX Venture Composite Index (INDEXTSI:JX)上周保持平稳,周五(6月9日)收于610.02点,但领涨的一只资源股的股价在短短五个交易日...查看全文
F1watch2023-06-02 04:40
F-1 - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-06-01 AccNo: 0001213900-23-045058 Size: 351 KB 网页链接查看全文
医麦客2023-04-15 07:36
2023年4月15日/医麦客新闻 eMedClub News/--mRNA疫苗技术已发展数十年,研究历史可追溯至20世纪60年代,近两年来疫情的爆发及大流行大大加快了mRNA技术的成熟。目前上市的mRNA产品仅新冠疫苗一类,其他产品仍在临床开发中。近年来的临床研究已表明,mRNA疫苗在疾病预防和肿瘤治疗等多个领域具有巨...查看全文
F1watch2023-03-27 22:40
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-03-27 AccNo: 0001213900-23-023002 Size: 15 MB 网页链接查看全文
F1watch2023-03-13 21:20
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-03-13 AccNo: 0001213900-23-019406 Size: 15 MB 网页链接查看全文
F1watch2023-03-02 02:10
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-03-01 AccNo: 0001213900-23-016044 Size: 15 MB 网页链接查看全文
$Auris Medical Holding AG(EARS)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-05-24 AccNo: 0001144204-18-030719 Size: 97 KB 网页链接
$Auris Medical Holding AG(EARS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-05-17 AccNo: 0000895421-18-000453 Size: 17 KB 网页链接
$Auris Medical Holding AG(EARS)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-05-15 AccNo: 0000950103-18-006139 Size: 289 KB 网页链接
$Auris Medical Holding AG(EARS)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-05-15 AccNo: 0000950103-18-006138 Size: 379 KB 网页链接
$Auris Medical Holding AG(EARS)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-05-15 AccNo: 0000950103-18-006139 Size: 289 KB 网页链接
$Auris Medical Holding AG(EARS)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-05-15 AccNo: 0000950103-18-006138 Size: 379 KB 网页链接
$Auris Medical Holding AG(EARS)$ F-1 - Registration statement for certain foreign private issuers Filed: 2018-05-11 AccNo: 0000950103-18-006095 Size: 542 KB 网页链接
$Auris Medical Holding AG(EARS)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-05-11 AccNo: 0000950103-18-006092 Size: 347 KB 网页链接
$Auris Medical Holding AG(EARS)$ EFFECT - Notice of Effectiveness Filed: 2018-05-10 AccNo: 9999999995-18-001204 Size: 1 KB 网页链接
$Auris Medical Holding AG(EARS)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-05-02 AccNo: 0000950103-18-005767 Size: 416 KB 网页链接